Acceptability of a COVID-19 Vaccine among the Saudi Population
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Sample
2.2. Measures
2.3. Outcome Measure
2.4. Explanatory Variables
2.5. Statistical Analyses
2.6. Ethical Consideration
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
Variables | OR | 95% CI | OR | 95% CI | OR | 95% CI |
Age | ||||||
18–29 | 1 | |||||
30–39 | 0.66 *** | 0.52–0.84 | ||||
40–49 | 0.67 *** | 0.52–0.88 | ||||
50–59 | 0.57 *** | 0.42.0.78 | ||||
≥ 60 | 0.56 *** | 0.40–0.78 | ||||
Gender | ||||||
Female | 1 | 1 | ||||
Male | 1.82 *** | 1.53–2.18 | 1.53 *** | 1.12–2.09 | ||
Marital status | ||||||
Unmarried | 1 | 1 | ||||
Married | 1.01 | 0.72–1.42 | 0.94 | 0.67–1.33 | ||
Education level | ||||||
High school or below | 1 | 1 | ||||
Bachelor’s degree | 0.82 | 0.60–1.12 | 0.86 | 0.62–1.18 | ||
Postgraduate degree | 0.80 | 0.55–1.18 | 0.87 | 0.59–1.29 | ||
Employment status | ||||||
Government employee | 1 | 1 | ||||
Nongovernment employee | 0.77 | 0.50–1.18 | 0.75 | 0.49–1.15 | ||
Self–employed | 0.70 | 0.35–1.37 | 0.69 | 0.35–1.36 | ||
Student | 1.30 | 0.69–2.44 | 1.52 | 0.79–2.90 | ||
Retired | 0.90 | 0.60–1.35 | 0.92 | 0.61–1.38 | ||
Unemployed | 1.01 | 0.63–1.60 | 1.32 | 0.79–2.19 | ||
Region of residence | ||||||
Central | 1 | 1 | ||||
South | 2.00 *** | 1.25–3.22 | 1.93 *** | 1.20–3.10 | ||
East | 1.27 | 0.78–2.07 | 1.30 | 0.80–2.12 | ||
North | 1.69 | 0.69–4.13 | 1.65 | 0.68–4.03 | ||
West | 0.99 | 0.70–1.42 | 1.02 | 0.71–1.45 | ||
Monthly income | ||||||
<3000 SAR | 1 | 1 | ||||
3000–˂5000 SAR | 1.59 | 0.90–2.82 | 1.65 * | 0.93–2.94 | ||
5000–˂7000 SAR | 1.29 | 0.70–2.37 | 1.35 | 0.73–2.48 | ||
7000–˂10,000 SAR | 1.07 | 0.60–1.89 | 1.10 | 0.62–1.97 | ||
10,000–˂15,000 SAR | 0.90 | 0.54–1.51 | 0.93 | 0.55–1.57 | ||
15,000–˂20,000 SAR | 1.08 | 0.62–1.87 | 1.05 | 0.60–1.83 | ||
20,000–˂30,000 SAR | 1.36 | 0.75–2.46 | 1.31 | 0.72–2.39 | ||
≥30,000 SAR | 1.97 ** | 1.10–3.53 | 1.88 ** | 1.04–3.40 | ||
Has chronic conditions | ||||||
No | 1 | 1 | ||||
Yes | 0.98 | 0.73–1.32 | 0.99 | 0.74–1.34 | ||
Received flu vaccination in the past | ||||||
No | 1 | 1 | ||||
Yes | 1.53 *** | 1.18–1.99 | 1.51 *** | 1.17–1.96 | ||
Refused vaccination in the past | ||||||
No | 1 | 1 | ||||
Yes | 0.27 *** | 0.19–0.38 | 0.28 *** | 0.19–0.40 | ||
Contracted COVID-19 | ||||||
No | 1 | 1 | ||||
Yes | 1.52 * | 0.99–2.34 | 1.48 * | 0.96–2.28 | ||
Family member contracted COVID-19 | ||||||
No | 1 | 1 | ||||
Yes | 1.06 | 0.82–1.39 | 1.09 | 0.84–1.43 | ||
Perceived risk of COVID-19 to people in Saudi Arabia | ||||||
Minor risk or no risk | 1 | 1 | ||||
Moderate risk | 1.04 | 0.73–1.48 | 1.04 | 0.73–1.49 | ||
Significant or major risk | 1.33 | 0.92–1.93 | 1.35 | 0.93–1.95 | ||
Concerned about contracting COVID-19 | ||||||
Low or very low | 1 | 1 | ||||
Fair | 2.05 *** | 1.47–2.84 | 2.06 *** | 1.48–2.85 | ||
High or very high | 1.86 *** | 1.26–2.75 | 1.89 *** | 1.28–2.79 | ||
COVID-19 vaccine should be compulsory for all citizens and residents in Saudi Arabia | ||||||
No | 1 | 1 | ||||
Yes | 46.08 *** | 32.61–65.12 | 44.94 *** | 31.78–63.55 |
References
- Al-Hanawi, M.K.; Mwale, M.L.; Alshareef, N.; Qattan, A.M.N.; Angawi, K.; Almubark, R.; Alsharqi, O. Psychological Distress Amongst Health Workers and the General Public During the COVID-19 Pandemic in Saudi Arabia. Risk Manag. Healthc. Policy 2020, 13, 733–742. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A Global Survey of Potential Acceptance of a COVID-19 Vaccine. Nat. Med. 2020, 27, 225–228. [Google Scholar] [CrossRef]
- Ten Health Issues WHO Will Tackle This Year. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 14 December 2020).
- Halpin, C.; Reid, B. Attitudes and Beliefs of Healthcare Workers about Influenza Vaccination. Nurs. Older People 2019, 31, 32–39. [Google Scholar] [CrossRef]
- Setbon, M.; Raude, J. Factors in Vaccination Intention against the Pandemic Influenza A/H1N1. Eur. J. Public Health 2010, 20, 490–494. [Google Scholar] [CrossRef] [Green Version]
- Nguyen, T.; Henningsen, K.H.; Brehaut, J.C.; Hoe, E.; Wilson, K. Acceptance of a Pandemic Influenza Vaccine: A Systematic Review of Surveys of the General Public. Infect. Drug Resist. 2011, 4, 197–207. [Google Scholar] [CrossRef] [Green Version]
- Bish, A.; Yardley, L.; Nicoll, A.; Michie, S. Factors Associated with Uptake of Vaccination against Pandemic Influenza: A Systematic Review. Vaccine 2011, 29, 6472–6484. [Google Scholar] [CrossRef]
- Thanh Le, T.; Andreadakis, Z.; Kumar, A.; Gómez Román, R.; Tollefsen, S.; Saville, M.; Mayhew, S. The COVID-19 Vaccine Development Landscape. Nat. Rev. Drug Discov. 2020, 19, 305–306. [Google Scholar] [CrossRef]
- Sharpe, H.R.; Gilbride, C.; Allen, E.; Belij-Rammerstorfer, S.; Bissett, C.; Ewer, K.; Lambe, T. The Early Landscape of Coronavirus Disease 2019 Vaccine Development in the UK and Rest of the World. Immunology 2020, 160, 223–232. [Google Scholar] [CrossRef]
- Palamenghi, L.; Barello, S.; Boccia, S.; Graffigna, G. Mistrust in Biomedical Research and Vaccine Hesitancy: The Forefront Challenge in the Battle against COVID-19 in Italy. Eur. J. Epidemiol. 2020, 35, 785–788. [Google Scholar] [CrossRef]
- COCONEL Group A Future Vaccination Campaign against COVID-19 at Risk of Vaccine Hesitancy and Politicisation. Lancet Infect. Dis. 2020, 20, 769–770. [CrossRef]
- Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef]
- Rhodes, A.; Hoq, M.; Measey, M.-A.; Danchin, M. Intention to Vaccinate against COVID-19 in Australia. Lancet Infect. Dis. 2020. [Google Scholar] [CrossRef]
- Jayasooriya, S.; Mitchell, C.; Balen, J.; Darton, T.C. Seasonal Influenza Programme Expansion. BMJ 2020, 371, m4713. [Google Scholar] [CrossRef]
- Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards Vaccines and Intention to Vaccinate against COVID-19: Implications for Public Health Communications. Lancet Reg. Health Eur. 2020, 1, 100012. [Google Scholar] [CrossRef]
- Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. Available online: https://www.dovepress.com/determinants-of-covid-19-vaccine-acceptance-in-saudi-arabia-a-web-base-peer-reviewed-article-JMDH (accessed on 19 December 2020).
- Saudi Arabia Ready to Launch Vaccine Campaign. Available online: https://www.arabnews.com/node/1775896/saudi-arabia (accessed on 12 December 2020).
- Al-Hanawi, M.K.; Angawi, K.; Alshareef, N.; Qattan, A.M.N.; Helmy, H.Z.; Abudawood, Y.; Alqurashi, M.; Kattan, W.M.; Kadasah, N.A.; Chirwa, G.C.; et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Front. Public Health 2020, 8, 217. [Google Scholar] [CrossRef]
- Sherman, S.M.; Smith, L.E.; Sim, J.; Amlôt, R.; Cutts, M.; Dasch, H.; Rubin, G.J.; Sevdalis, N. COVID-19 Vaccination Intention in the UK: Results from the COVID-19 Vaccination Acceptability Study (CoVAccS), a Nationally Representative Cross-Sectional Survey. Hum. Vaccines Immunother. 2020, 0, 1–10. [Google Scholar] [CrossRef]
- MacDonald, N.E. Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
- Kabamba Nzaji, M.; Kabamba Ngombe, L.; Ngoie Mwamba, G.; Banza Ndala, D.B.; Mbidi Miema, J.; Luhata Lungoyo, C.; Lora Mwimba, B.; Cikomola Mwana Bene, A.; Mukamba Musenga, E. Acceptability of Vaccination Against COVID-19 Among Healthcare Workers in the Democratic Republic of the Congo. Pragmatic Obs. Res. 2020, 11, 103–109. [Google Scholar] [CrossRef] [PubMed]
- Harapan, H.; Wagner, A.L.; Yufika, A.; Winardi, W.; Anwar, S.; Gan, A.K.; Setiawan, A.M.; Rajamoorthy, Y.; Sofyan, H.; Mudatsir, M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front. Public Health 2020, 8. [Google Scholar] [CrossRef]
- Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef]
- Quinn, S.C.; Jamison, A.M.; An, J.; Hancock, G.R.; Freimuth, V.S. Measuring Vaccine Hesitancy, Confidence, Trust and Flu Vaccine Uptake: Results of a National Survey of White and African American Adults. Vaccine 2019, 37, 1168–1173. [Google Scholar] [CrossRef]
- Jones, A.M. Data Visualization and Health Econometrics. Found. Trends® Econom. 2017, 9, 1–78. [Google Scholar] [CrossRef] [Green Version]
- Wooldridge, J.M. Econometric Analysis of Cross Section and Panel Data; MIT Press: Cambridge, MA, USA, 2010. [Google Scholar]
- Cameron, A.C.; Trivedi, P.K. Microeconometrics Using Stata; Stata Press: College Station, TX, USA, 2010; Volume 2. [Google Scholar]
- Chirwa, G.C. “Who Knows More, and Why?” Explaining Socioeconomic-Related Inequality in Knowledge about HIV in Malawi. Sci. Afr. 2020, 7, e00213. [Google Scholar] [CrossRef]
- Rubin, G.J.; Potts, H.W.W.; Michie, S. The Impact of Communications about Swine Flu (Influenza A H1N1v) on Public Responses to the Outbreak: Results from 36 National Telephone Surveys in the UK. Health Technol. Assess. Winch. Engl. 2010, 14, 183–266. [Google Scholar] [CrossRef] [Green Version]
- Ofri, D. The Emotional Epidemiology of H1N1 Influenza Vaccination. N. Engl. J. Med. 2009, 361, 2594–2595. [Google Scholar] [CrossRef] [PubMed]
- Dubé, E.; Gagnon, D.; Nickels, E.; Jeram, S.; Schuster, M. Mapping Vaccine Hesitancy—Country-Specific Characteristics of a Global Phenomenon. Vaccine 2014, 32, 6649–6654. [Google Scholar] [CrossRef] [Green Version]
- Brewer, N.T.; Chapman, G.B.; Gibbons, F.X.; Gerrard, M.; McCaul, K.D.; Weinstein, N.D. Meta-Analysis of the Relationship between Risk Perception and Health Behavior: The Example of Vaccination. Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. Assoc. 2007, 26, 136–145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- CDC Frequently Asked Questions about COVID-19 Vaccination. Available online: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html (accessed on 26 February 2021).
- Men, Sex, Gender and COVID-19|Global Health 50/50. Available online: https://globalhealth5050.org/the-sex-gender-and-covid-19-project/men-sex-gender-and-covid-19/ (accessed on 29 January 2021).
- Tuqa Khalid Coronavirus in Saudi Arabia: Most Cases Reported in Mecca, Riyadh, Jeddah, Medina. Available online: https://english.alarabiya.net/coronavirus/2020/05/14/Coronavirus-in-Saudi-Arabia-Most-cases-reported-in-Mecca-Riyadh-Jeddah-Medina (accessed on 20 May 2020).
Variables | Willingness to Accept a COVID-19 Vaccine | |||
---|---|---|---|---|
Yes 1034 (48%) | No 1103 (52%) | Chi-Square | p-Value | |
Age | ||||
18–29 | 246 (23.8) | 205 (18.6) | 11.2305 | 0.024 ** |
30–39 | 341 (33) | 379 (34.4) | ||
40–49 | 233 (22.5) | 245 (22.2) | ||
50–59 | 120 (11.6) | 156 (14.1) | ||
≥60 | 94 (9.1) | 118 (10.7) | ||
Gender | ||||
Female | 372 (36) | 538 (48.8) | 35.759 | 0.000 *** |
Male | 662 (64) | 565 (51.2) | ||
Marital status | ||||
Unmarried | 300 (29) | 282 (25.6) | 3.1997 | 0.074 * |
Married | 734 (71) | 821 (74.4) | ||
Education level | ||||
High school or below | 290 (28) | 229 (20.8) | 19.4839 | 0.000 *** |
Bachelor’s degree | 485 (46.9) | 527 (47.8) | ||
Postgraduate degree | 259 (25) | 347 (31.5) | ||
Employment status | ||||
Government employee | 477 (46.1) | 494 (44.8) | 28.9683 | 0.000 *** |
Nongovernment employee | 140 (13.5) | 158 (14.3) | ||
Self-employed | 39 (3.8) | 52 (4.7) | ||
Student | 134 (13) | 75 (6.8) | ||
Retired | 108 (10.4) | 143 (13) | ||
Unemployed | 136 (13.2) | 181 (16.4) | ||
Region of residence | ||||
Central | 129 (12.5) | 188 (17) | 38.9615 | 0.000 *** |
South | 187 (18.1) | 104 (9.4) | ||
East | 103 (10) | 121(11) | ||
North | 19 (1.8) | 16 (1.5) | ||
West | 596 (57.6) | 674 (61.1) | ||
Monthly income | ||||
˂3000 SAR | 209 (20.2) | 196 (17.8) | 9.6153 | 0.211 |
3000–˂5000 SAR | 84 (8.1) | 64 (5.8) | ||
5000–˂7000 SAR | 63 (6.1) | 70 (6.3) | ||
7000–˂10,000 SAR | 111 (10.7) | 142 (12.9) | ||
10,000–˂15,000 SAR | 219 (21.2) | 253 (22.9) | ||
15,000–˂20,000 SAR | 152 (14.7) | 172 (15.6) | ||
20,000–˂30,000 SAR | 97 (9.4) | 110 (10) | ||
≥30,000 SAR | 99 (9.6) | 96 (8.7) | ||
Has chronic conditions | ||||
No | 764 (73.9) | 852 (77.2) | 3.2605 | 0.071 * |
Yes | 270 (26.1) | 251 (22.8) | ||
Received flu vaccination in the past | ||||
No | 348 (33.7) | 573 (51.9) | 72.8286 | 0.000 *** |
Yes | 686 (66.3) | 530 (48.1) | ||
Refused vaccination in the past | ||||
No | 951 (92) | 767 (69.5) | 170.4225 | 0.000 *** |
Yes | 83 (8) | 336 (30.5) | ||
Contracted COVID-19 | ||||
No | 899 (86.9) | 947 (85.9) | 0.5362 | 0.464 |
Yes | 135 (13.1) | 156 (14.1) | ||
Family members contracted COVID-19 | ||||
No | 642 (62.1) | 652 (59.1) | 1.9808 | 0.15 |
Yes | 392 (37.9) | 451 (40.9) | ||
Perceived risk of COVID-19 to people in Saudi Arabia | ||||
Minor risk or no risk | 149 (14.4) | 283 (25.7) | 89.2711 | 0.000 *** |
Moderate risk | 350 (33.8) | 461 (41.8) | ||
Significant or major risk | 535 (51.7) | 359 (32.5) | ||
Concerned about contracting COVID-19 | ||||
Low or very low | 320 (30.9) | 550 (49.9) | 84.9969 | 0.000 *** |
Fair | 377 (36.5) | 330 (29.9) | ||
High or very high | 337 (32.6) | 223 (20.2) | ||
COVID-19 vaccine should be compulsory for all citizens and residents in Saudi Arabia | ||||
No | 315 (30.5) | 1,057.00 (95.8) | 992.1562 | 0.000 *** |
Yes | 719 (69.5) | 46 (4.2) |
Variables | OR | 95% CI |
---|---|---|
Age | ||
18–29 | 1 | |
30–39 | 0.94 | 0.60–1.46 |
40–49 | 1.04 | 0.63–1.71 |
50–59 | 0.87 | 0.49–1.54 |
≥60 | 1.2 | 0.60–2.39 |
Gender | ||
Female | 1 | |
Male | 1.51 ** | 1.10–2.06 |
Marital status | ||
Unmarried | 1 | |
Married | 0.95 | 0.66–1.36 |
Education level | ||
High school or below | 1 | |
Bachelor’s degree | 0.85 | 0.61–1.18 |
Postgraduate degree | 0.87 | 0.58–1.29 |
Employment status | ||
Government employee | 1 | |
Nongovernment employee | 0.75 | 0.48–1.16 |
Self-employed | 0.68 | 0.34–1.36 |
Student | 1.48 | 0.74–2.95 |
Retired | 0.83 | 0.48–1.43 |
Unemployed | 1.29 | 0.77–2.16 |
Region of residence | ||
Central | 1 | |
South | 1.95 *** | 1.21–3.14 |
East | 1.31 | 0.80–2.13 |
North | 1.65 | 0.68–4.02 |
West | 1.02 | 0.71–1.45 |
Monthly income | ||
<3000 SAR | 1 | |
3000–˂5000 SAR | 1.64 * | 0.92–2.92 |
5000–˂7000 SAR | 1.34 | 0.73–2.47 |
7000–˂10,000 SAR | 1.11 | 0.62–1.97 |
10,000–˂15,000 SAR | 0.94 | 0.55–1.59 |
15,000–˂20,000 SAR | 1.06 | 0.60–1.87 |
20,000–˂30,000 SAR | 1.29 | 0.70–2.40 |
≥30,000 SAR | 1.85 * | 0.99–3.45 |
Has chronic conditions | ||
No | 1 | |
Yes | 0.98 | 0.72–1.34 |
Received flu vaccination in the past | ||
No | 1 | |
Yes | 1.52 *** | 1.17–1.97 |
Refused vaccination in the past | ||
No | 1 | |
Yes | 0.28 *** | 0.19–0.40 |
Contracted COVID-19 | ||
No | 1 | |
Yes | 1.48 * | 0.97–2.27 |
Family member contracted COVID-19 | ||
No | 1 | |
Yes | 1.1 | 0.84–1.43 |
Perceived risk of COVID-19 to people in Saudi Arabia | ||
Minor risk or no risk | 1 | |
Moderate risk | 1.04 | 0.73–1.48 |
Significant or major risk | 1.34 | 0.92–1.95 |
Concerned about contracting COVID-19 | ||
Low or very low | 1 | |
Fair | 2.06 *** | 1.49–2.86 |
High or very high | 1.91 *** | 1.29–2.81 |
COVID-19 vaccine should be compulsory for all citizens and residents in Saudi Arabia | ||
No | 1 | |
Yes | 45.07 *** | 31.91–63.65 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alfageeh, E.I.; Alshareef, N.; Angawi, K.; Alhazmi, F.; Chirwa, G.C. Acceptability of a COVID-19 Vaccine among the Saudi Population. Vaccines 2021, 9, 226. https://doi.org/10.3390/vaccines9030226
Alfageeh EI, Alshareef N, Angawi K, Alhazmi F, Chirwa GC. Acceptability of a COVID-19 Vaccine among the Saudi Population. Vaccines. 2021; 9(3):226. https://doi.org/10.3390/vaccines9030226
Chicago/Turabian StyleAlfageeh, Eman Ibrahim, Noor Alshareef, Khadijah Angawi, Fahad Alhazmi, and Gowokani Chijere Chirwa. 2021. "Acceptability of a COVID-19 Vaccine among the Saudi Population" Vaccines 9, no. 3: 226. https://doi.org/10.3390/vaccines9030226
APA StyleAlfageeh, E. I., Alshareef, N., Angawi, K., Alhazmi, F., & Chirwa, G. C. (2021). Acceptability of a COVID-19 Vaccine among the Saudi Population. Vaccines, 9(3), 226. https://doi.org/10.3390/vaccines9030226